Lower-limb drainage mapping for lymphedema risk reduction after pelvic lymphadenectomy for endometrial cancer.
Identifieur interne : 001D46 ( PubMed/Corpus ); précédent : 001D45; suivant : 001D47Lower-limb drainage mapping for lymphedema risk reduction after pelvic lymphadenectomy for endometrial cancer.
Auteurs : Anne-Sophie Bats ; Claude Nos ; Chérazade Bensaïd ; Marie-Aude Le Frère-Belda ; Marie-Anne Collignon ; Marc Faraggi ; Fabrice LécuruSource :
- The oncologist [ 1549-490X ] ; 2013.
English descriptors
- KwdEn :
- Aged, Endometrial Neoplasms (pathology), Endometrial Neoplasms (surgery), Female, Humans, Leg (anatomy & histology), Leg (blood supply), Leg (pathology), Lymph Node Excision (methods), Lymphedema (diagnosis), Lymphedema (pathology), Lymphedema (prevention & control), Lymphedema (therapy), Middle Aged, Pelvis (surgery), Pilot Projects, Prospective Studies, Risk Factors, Tomography, Emission-Computed, Single-Photon.
- MESH :
- anatomy & histology : Leg.
- blood supply : Leg.
- diagnosis : Lymphedema.
- methods : Lymph Node Excision.
- pathology : Endometrial Neoplasms, Leg, Lymphedema.
- prevention & control : Lymphedema.
- surgery : Endometrial Neoplasms, Pelvis.
- therapy : Lymphedema.
- Aged, Female, Humans, Middle Aged, Pilot Projects, Prospective Studies, Risk Factors, Tomography, Emission-Computed, Single-Photon.
Abstract
Pelvic lymphadenectomy is associated with a significant risk of lower-limb lymphedema. In this proof-of-concept study, we evaluated the feasibility of identifying the lower-limb drainage nodes (LLDNs) during pelvic lymphadenectomy for endometrial cancer. Secondary objectives were to map lower-limb drainage and to assess the diagnostic value of our mapping technique.
DOI: 10.1634/theoncologist.2012-0309
PubMed: 23335621
Links to Exploration step
pubmed:23335621Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lower-limb drainage mapping for lymphedema risk reduction after pelvic lymphadenectomy for endometrial cancer.</title><author><name sortKey="Bats, Anne Sophie" sort="Bats, Anne Sophie" uniqKey="Bats A" first="Anne-Sophie" last="Bats">Anne-Sophie Bats</name><affiliation><nlm:affiliation>Department of Medicine, INSERM UMR-S 747, Université Paris Descartes, Faculté de Médecine, Sorbonne Paris Cité, Paris, France. anne-sophie.bats@egp.aphp.fr</nlm:affiliation></affiliation></author><author><name sortKey="Nos, Claude" sort="Nos, Claude" uniqKey="Nos C" first="Claude" last="Nos">Claude Nos</name></author><author><name sortKey="Bensaid, Cherazade" sort="Bensaid, Cherazade" uniqKey="Bensaid C" first="Chérazade" last="Bensaïd">Chérazade Bensaïd</name></author><author><name sortKey="Le Frere Belda, Marie Aude" sort="Le Frere Belda, Marie Aude" uniqKey="Le Frere Belda M" first="Marie-Aude" last="Le Frère-Belda">Marie-Aude Le Frère-Belda</name></author><author><name sortKey="Collignon, Marie Anne" sort="Collignon, Marie Anne" uniqKey="Collignon M" first="Marie-Anne" last="Collignon">Marie-Anne Collignon</name></author><author><name sortKey="Faraggi, Marc" sort="Faraggi, Marc" uniqKey="Faraggi M" first="Marc" last="Faraggi">Marc Faraggi</name></author><author><name sortKey="Lecuru, Fabrice" sort="Lecuru, Fabrice" uniqKey="Lecuru F" first="Fabrice" last="Lécuru">Fabrice Lécuru</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23335621</idno><idno type="pmid">23335621</idno><idno type="doi">10.1634/theoncologist.2012-0309</idno><idno type="wicri:Area/PubMed/Corpus">001D46</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001D46</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lower-limb drainage mapping for lymphedema risk reduction after pelvic lymphadenectomy for endometrial cancer.</title><author><name sortKey="Bats, Anne Sophie" sort="Bats, Anne Sophie" uniqKey="Bats A" first="Anne-Sophie" last="Bats">Anne-Sophie Bats</name><affiliation><nlm:affiliation>Department of Medicine, INSERM UMR-S 747, Université Paris Descartes, Faculté de Médecine, Sorbonne Paris Cité, Paris, France. anne-sophie.bats@egp.aphp.fr</nlm:affiliation></affiliation></author><author><name sortKey="Nos, Claude" sort="Nos, Claude" uniqKey="Nos C" first="Claude" last="Nos">Claude Nos</name></author><author><name sortKey="Bensaid, Cherazade" sort="Bensaid, Cherazade" uniqKey="Bensaid C" first="Chérazade" last="Bensaïd">Chérazade Bensaïd</name></author><author><name sortKey="Le Frere Belda, Marie Aude" sort="Le Frere Belda, Marie Aude" uniqKey="Le Frere Belda M" first="Marie-Aude" last="Le Frère-Belda">Marie-Aude Le Frère-Belda</name></author><author><name sortKey="Collignon, Marie Anne" sort="Collignon, Marie Anne" uniqKey="Collignon M" first="Marie-Anne" last="Collignon">Marie-Anne Collignon</name></author><author><name sortKey="Faraggi, Marc" sort="Faraggi, Marc" uniqKey="Faraggi M" first="Marc" last="Faraggi">Marc Faraggi</name></author><author><name sortKey="Lecuru, Fabrice" sort="Lecuru, Fabrice" uniqKey="Lecuru F" first="Fabrice" last="Lécuru">Fabrice Lécuru</name></author></analytic><series><title level="j">The oncologist</title><idno type="eISSN">1549-490X</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Endometrial Neoplasms (pathology)</term><term>Endometrial Neoplasms (surgery)</term><term>Female</term><term>Humans</term><term>Leg (anatomy & histology)</term><term>Leg (blood supply)</term><term>Leg (pathology)</term><term>Lymph Node Excision (methods)</term><term>Lymphedema (diagnosis)</term><term>Lymphedema (pathology)</term><term>Lymphedema (prevention & control)</term><term>Lymphedema (therapy)</term><term>Middle Aged</term><term>Pelvis (surgery)</term><term>Pilot Projects</term><term>Prospective Studies</term><term>Risk Factors</term><term>Tomography, Emission-Computed, Single-Photon</term></keywords><keywords scheme="MESH" qualifier="anatomy & histology" xml:lang="en"><term>Leg</term></keywords><keywords scheme="MESH" qualifier="blood supply" xml:lang="en"><term>Leg</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Endometrial Neoplasms</term><term>Leg</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Endometrial Neoplasms</term><term>Pelvis</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Pilot Projects</term><term>Prospective Studies</term><term>Risk Factors</term><term>Tomography, Emission-Computed, Single-Photon</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Pelvic lymphadenectomy is associated with a significant risk of lower-limb lymphedema. In this proof-of-concept study, we evaluated the feasibility of identifying the lower-limb drainage nodes (LLDNs) during pelvic lymphadenectomy for endometrial cancer. Secondary objectives were to map lower-limb drainage and to assess the diagnostic value of our mapping technique.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23335621</PMID><DateCreated><Year>2013</Year><Month>02</Month><Day>25</Day></DateCreated><DateCompleted><Year>2013</Year><Month>12</Month><Day>12</Day></DateCompleted><DateRevised><Year>2015</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1549-490X</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>2</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>The oncologist</Title><ISOAbbreviation>Oncologist</ISOAbbreviation></Journal><ArticleTitle>Lower-limb drainage mapping for lymphedema risk reduction after pelvic lymphadenectomy for endometrial cancer.</ArticleTitle><Pagination><MedlinePgn>174-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1634/theoncologist.2012-0309</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Pelvic lymphadenectomy is associated with a significant risk of lower-limb lymphedema. In this proof-of-concept study, we evaluated the feasibility of identifying the lower-limb drainage nodes (LLDNs) during pelvic lymphadenectomy for endometrial cancer. Secondary objectives were to map lower-limb drainage and to assess the diagnostic value of our mapping technique.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective study included patients with endometrial cancer requiring pelvic lymphadenectomy, without neoadjuvant radiotherapy or chemotherapy and without history of lower-limb surgery. A radiopharmaceutical was injected into both feet on the day before surgery. LLDNs were identified using preoperative lymphoscintigraphy and intraoperative isotopic probe detection, then removed before complete pelvic lymphadenectomy. LLDNs and pelvic lymphadenectomy specimens underwent separate histological analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 12 patients with early-stage endometrial cancer, 10 underwent preoperative lymphoscintigraphy, which consistently identified inguinal, femoral, and pelvic LLDNs (detection rate: 100%). The intraoperative detection rate was 83% (10/12). Median number of hot nodes per patient was 5 nodes (range: 3-7) on the right and 3 nodes (range: 2-6) on the left. Of 107 LLDNs, 106 were in the external iliac area, including 38 in the lateral group and 45 in the intermediate and medial groups. None of the patients had node metastases at any site. No early complications related to the technique occurred.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our mapping technique appears feasible, safe, and associated with a high LLDN identification rate. LLDN mapping may allow the preservation of LLDNs, thereby decreasing the risk of lower-limb lymphedema and improving quality of life.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bats</LastName><ForeName>Anne-Sophie</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Medicine, INSERM UMR-S 747, Université Paris Descartes, Faculté de Médecine, Sorbonne Paris Cité, Paris, France. anne-sophie.bats@egp.aphp.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nos</LastName><ForeName>Claude</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Bensaïd</LastName><ForeName>Chérazade</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Le Frère-Belda</LastName><ForeName>Marie-Aude</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Collignon</LastName><ForeName>Marie-Anne</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Faraggi</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Lécuru</LastName><ForeName>Fabrice</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncologist</MedlineTA><NlmUniqueID>9607837</NlmUniqueID><ISSNLinking>1083-7159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 2009 Jul;92(1):22-33</RefSource><PMID Version="1">19095323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2009 Jan 10;373(9658):125-36</RefSource><PMID Version="1">19070889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2010 Apr 3;375(9721):1165-72</RefSource><PMID Version="1">20188410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Gynecol Cancer. 2011 Apr;21(3):582-6</RefSource><PMID Version="1">21436707</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2011 May;12(5):469-76</RefSource><PMID Version="1">21489874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 2011 Jul;122(1):55-8</RefSource><PMID Version="1">21507473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2012 Jan;19(1):268-73</RefSource><PMID Version="1">21717243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Gynecol Cancer. 2012 Jul;22(6):1069-74</RefSource><PMID Version="1">22665042</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med. 2001 Mar;110(4):288-95</RefSource><PMID Version="1">11239847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 1988 Mar;29(3):333-6</RefSource><PMID Version="1">3345953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Chir. 1989;43(7):525-9</RefSource><PMID Version="1">2694906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pain Symptom Manage. 1992 Feb;7(2):110-6</RefSource><PMID Version="1">1573284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pain Symptom Manage. 1996 Dec;12(6):376-9</RefSource><PMID Version="1">8973048</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 1997 Jun;24(5):875-82</RefSource><PMID Version="1">9201739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2798-802</RefSource><PMID Version="1">9874400</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Obstet Gynecol. 1999 Sep;94(3):391-4</RefSource><PMID Version="1">10472865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 2006 Oct;103(1):35-44</RefSource><PMID Version="1">16600355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 2006 Nov;103(2):714-8</RefSource><PMID Version="1">16740298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 2007 Jul;106(1):4-5</RefSource><PMID Version="1">17477957</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2007 Sep;14(9):2490-6</RefSource><PMID Version="1">17549570</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2007 Oct;8(10):881-8</RefSource><PMID Version="1">17851130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2008 Sep;15(9):2550-5</RefSource><PMID Version="1">18618185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2010;(1):CD007585</RefSource><PMID Version="1">20091639</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016889" MajorTopicYN="N">Endometrial Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007866" MajorTopicYN="N">Leg</DescriptorName><QualifierName UI="Q000033" MajorTopicYN="N">anatomy & histology</QualifierName><QualifierName UI="Q000098" MajorTopicYN="Y">blood supply</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010388" MajorTopicYN="N">Pelvis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015899" MajorTopicYN="N">Tomography, Emission-Computed, Single-Photon</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3579601</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23335621</ArticleId><ArticleId IdType="pii">theoncologist.2012-0309</ArticleId><ArticleId IdType="doi">10.1634/theoncologist.2012-0309</ArticleId><ArticleId IdType="pmc">PMC3579601</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D46 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001D46 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:23335621
|texte= Lower-limb drainage mapping for lymphedema risk reduction after pelvic lymphadenectomy for endometrial cancer.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:23335621" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |